Here are relevant reports on : biopharmaceutical-cro-services-market
-
Hollow Fiber Filtration Market Size, Share & Trends by Material (Polymer (PES, PVDF), Ceramic), Technique (Microfiltration, Ultrafiltration), Application (Harvest & Clarification, Concentration, Diafiltration), End User (Pharma, Biotech, CRO, CMO) & Region - Global Forecast to 2026
The size of global hollow fiber filtration market in terms of revenue was estimated to be worth USD 303 million in 2021 and is poised to reach USD 597 million by 2026, growing at a CAGR of 14.5% from 2021 to 2026. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: June 2021
- Price: $ 4950
- TOC Available:
-
Continuous Manufacturing Market By Product (Integrated system, Semi-continuous (Granulator, Coater, Blender), Control), Application (API, End Product (Solid Dosage)), End User (R&D Department (CRO), Pharmaceutical Companies, CMO)- Global Forecast to 2022
The global continuous manufacturing market is projected to grow at a CAGR of 13.3%. Major players in this market include GEA Group AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bosch Packaging Technology (Germany), Coperion GmbH (Germany), and Glatt GmbH (Germany). Other players include KORSCH AG (Germany), Munson Machinery Company, Inc. (U.S.), L.B. Bohle Maschinen + Verfahren Gmbh (Germany), Gebrüder Lödige Maschinenbau GmbH (Germany), Baker Perkins Ltd. (U.K.), Scott Equipment Company (U.S.), and Sturtevant, Inc. (U.S.).
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
qPCR Reagents Market by Detection (Dye-based, Probe-based), Packaging (qPCR Core Kits, Master Mixes), End User (Hospitals, Diagnostic Centers, Academia, Research Labs, CRO), Application (Diagnostic, Research, Forensic) - Global Forecast to 2020
The global qPCR reagents market size is projected to grow at a CAGR of 7.7%. Market growth can be attributed to factors such as rising patient population base for infectious diseases & genetic disorders, coupled with growing geriatric population, technological advancements in the life sciences sector, increasing public-private investments, funds, and grants for PCR-based research, and the successful completion of the human genome project. However, technical limitations associated with qPCR are restraining the growth of this market.
- Published: January 2016
- Price: $ 4950
- TOC Available:
-
Electronic Chemicals CDMO & CRO Market by Type (High Performance Polymers, Acid & Base Chemicals, Gases, Metals & Pastes), Scale, Application (Photoresist, Etchants, Dopants, Cleaning, Deposition), End-Use & Region-Global Forecast to 2029
The electronic chemicals CDMO & CRO market is expected to grow from USD 0.48 billion in 2024 to USD 0.66 billion by 2029, at a CAGR of 6.8% during the forecast period. The Electronic Chemicals CDMO & CRO Market report comprises key service providers such as Sajjan India Ltd. (India), Cohance Lifesciences (India), noctiluca (Poland), Actylis (US), AGC Inc. (Japan), Navin Fluorine International limited (India), CABB Group GmbH (Germany), Adesis Inc. (US), Inventys Research Company (India), LinkChem Technology Co.,Ltd.(China), among others.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
miRNA Sequencing and Assay Market by Product (Library Preparation, Consumables), Technology (Sequencing By Synthesis, Nanopore, Ion Semiconductor Sequencing), End User (Research Institute, Academia, CRO), Region - Global Forecast To 2024
The miRNA sequencing and assays market is projected to reach USD 343 million by 2024, at a CAGR of 11.2%. Growth in this market is driven by factors such as the advantages of miRNA sequencing over other technologies, increasing research funding for genomics, and the decreasing cost of sequencing.Illumina (US), Thermo Fisher Scientific (US), QIAGEN (Germany), Takara Bio (Japan), NEB (UK), and 5 others.
- Published: March 2019
- Price: $ 4950
- TOC Available:
-
Molecular Weight Marker Market by Products (DNA, RNA, Protein Ladders), Type (Prestained, Specialty), Application (PCR, Western Blotting, Gel Extraction), & End User (Academic Institutes, Pharmaceutical Companies, CRO) - Global Forecast to 2019
The global molecular weight marker market was valued at $265.36 million in 2014 and is poised to grow at a CAGR of 12.23 % between 2014 and 2019, to reach $472.47 million in 2019. Increased research and development spending by biotechnology and pharmaceutical companies, increasing public funding for life science research, and new innovations in genomics and proteomics research will drive the growth of the molecular weight markers market.
- Published: February 2015
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Quality Management Software (QMS) Market by Process (Clinical Trial, Regulatory, Manufacturing, Commercialization), Application (eSOP, CAPA, Compliance), Size (Large, Small), End User (pharma, biotech, CRO), Region - Global Forecast to 2030
The global pharmaceutical quality management software market is projected to reach USD 2.98 billion by 2030 from USD 1.59 billion in 2025, at a high CAGR of 13.3% during the forecast period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, NGS, PCR, Microscopy, Centrifuge, Liquid Handling), Application (Diagnostic, Research), End User (Pharma-Biopharma, Food, Hospital, Academia, CRO) - Global Forecast to 2031
The global life science instrumentation market is projected to reach USD 92.53 billion by 2031, growing at a CAGR of 6.5% during the forecast period (20252031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Preclinical Imaging Market by Product (Optical Imaging (Bioluminescence), Nuclear Imaging (PET, SPECT), MRI, Reagents (Luciferins, Infrared Dyes), Software), Application (Onco, Cardio), End User (Pharma, Biotech, Academic, CRO) - Global Forecast to 2030
The global preclinical imaging market, valued at US$3.36 billion in 2024, stood at US$3.53 billion in 2025 and is projected to advance at a resilient CAGR of 4.5% from 2025 to 2030, culminating in a forecasted valuation of US$4.39 billion by the end of the period.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Biosimulation Market by Phase (Drug Discovery, Preclinical, Regulatory), Modality (Antibody, Peptide), Application (Molecular Design, PK/PD, QSP, Trial Simulation, Disease Modeling), Indication (Cardio, Onco), End User (CRO, Pharma) Global Forecast to 2031
The global biosimulation market is projected to reach USD 9.24 billion by 2031, growing at a CAGR of 16.7% during the forecast period (20262031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
